(Q36447438)

English

Characterization and inhibition of SARS-coronavirus main protease

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

14 August 2017

1 reference

Europe PubMed Central

title

Characterization and inhibition of SARS-coronavirus main protease (English)

1 reference

stated in

Europe PubMed Central

14 August 2017

0 references

1 reference

1 reference

3C-like proteinase [SARS-Cov]

0 references

author name string

Po-Huang Liang

series ordinal

1

1 reference

stated in

Europe PubMed Central

14 August 2017

1 January 2006

1 reference

stated in

Europe PubMed Central

14 August 2017

Current Topics in Medicinal Chemistry

1 reference

stated in

Europe PubMed Central

14 August 2017

6

1 reference

stated in

Europe PubMed Central

14 August 2017

361-376

1 reference

stated in

Europe PubMed Central

14 August 2017

4

1 reference

stated in

Europe PubMed Central

14 August 2017

Synthesis and evaluation of keto-glutamine analogues as potent inhibitors of severe acute respiratory syndrome 3CLpro

1 reference

5 May 2024

https://opencitations.net/index/api/v1/citations/10.1021/JM0494873

Identifiers

DOI

10.2174/156802606776287090

1 reference

stated in

Europe PubMed Central

14 August 2017

release_ds7zx6zw4zfkvlnqwdg7g3fdya

1 reference

stated in

Fatcat

reference URL

https://api.fatcat.wiki/v0/release/ds7zx6zw4zfkvlnqwdg7g3fdya

retrieved

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed ID

16611148

1 reference

stated in

Europe PubMed Central

PubMed ID

16611148

retrieved

14 August 2017

(Q36447438)

Characterization and inhibition of SARS-coronavirus main protease

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)